title: Reply to: From the CUPIC study: great times are not coming (?).
authors.affiliation: INSERM UMR-S 707, Université Pierre et Marie Curie Paris 6, Paris, France; Department of Public Health, Hôpital Saint-Antoine, AP-HP, Paris, France.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Carrat
authors.affiliation: INSERM UMR-S 707, Université Pierre et Marie Curie Paris 6, Paris, France.
authors.forename: Yoann
authors.initials: Y
authors.lastname: Barthe
authors.affiliation: Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, AP-HP, Université Paris-Est, INSERM U955, Créteil, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Hezode
authors.affiliation: Department of Hepatology, Hôpital Cochin, APHP, Université Paris-René Descartes, INSERM U1016, Paris, France.
authors.forename: Helene
authors.initials: H
authors.lastname: Fontaine
authors.affiliation: Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire de Nancy, Université de Lorraine, INSERM U954, Vandoeuvre-les-Nancy, France. Electronic address: jp.bronowicki@chu-nancy.fr.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Bronowicki
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline